HOME >> BIOLOGY >> NEWS
Complementary therapy for infertile women may reduce chances of pregnancy

Complementary therapies in assisted reproduction may diminish the effectiveness of medical treatment for infertility in women, a scientist will tell the 23rd annual conference of the European Society of Human Reproduction and Embryology in Lyon, France, (Wednesday 4 July). Dr. Jacky Boivin, from the School of Psychology, Cardiff University, Wales, UK, will say that her research had also shown that women who used complementary therapies were more negatively affected by their fertility problems than non-users, and that this could account for the fact that they were willing to use complementary therapies that were not proven to improve fertility.

Many women use complementary or alternative therapies (CATs) to resolve fertility problems, even though there is little evidence that they are effective. However, it is not clear whether people use these to reduce stress or to increase their chances of getting pregnant. So Dr. Boivin and a colleague from the University of Copenhagen, Dr. Lone Schmidt, set out to study why women made these choices, in the hope of being able to better inform them both of their effectiveness and of other options for achieving pregnancy and reducing the stress of infertility.

They examined the psychosocial and medical profiles of 818 Danish women at the start of their IVF treatment, and then looked at which women went on to use complementary therapy in the subsequent 12 months. The study was the first large scale prospective evaluation of CAT use in an infertile population.

We found that women who went on to use complementary therapies for example reflexology and nutritional supplements during their treatments were more distressed and emotionally affected by their fertility problems than non-users, says Dr. Boivin. This difference in stress may mean that women used CATs for stress reduction, and if this were the case it would be important for future research to establish whether CATs achieve this goal mo
'"/>

Contact: Mary Rice
mary@mrcommunication.org
European Society for Human Reproduction and Embryology
4-Jul-2007


Page: 1 2

Related biology news :

1. Complementary new titles offer comprehensive view of antibiotics and resistance
2. Testosterone replacement therapy: How safe for aging men?
3. Progesterone therapy and preterm birth: More evidence helps identify women who can benefit
4. Aggressive therapy best for certain AML patients
5. Under magnetic force, nanoparticles may deliver gene therapy
6. 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
7. Stem cell therapy rescues motor neurons in ALS model
8. Study identifies new gene therapy tools for inherited blindness
9. Breast cancer and hormone therapy -- A looking-glass mirror?
10. Radiation therapy combined with microsurgery shows promise for curing injured spinal cord
11. Nodal status is best predictor of outcome after neoadjuvant therapy for esophageal cancer

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/11/2017)... MELBOURNE, Florida , April 11, 2017 ... "Company"), a security technology company, announces the appointment of independent ... John Bendheim to its Board of Directors, furthering the ... ... behalf of NXT-ID, we look forward to their guidance and ...
(Date:4/4/2017)... YORK , April 4, 2017   EyeLock ... today announced that the United States Patent and Trademark ... patent broadly covers the linking of an iris image ... same transaction) and represents the company,s 45 th ... latest patent is very timely given the multi-modal biometric ...
(Date:3/29/2017)... the health IT company that operates the largest health ... today announced a Series B investment from BlueCross BlueShield ... investment and acquisition accelerates higi,s strategy to create the ... activities through the collection and workflow integration of ambient ... secures data today on behalf of over 36 million ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... LAGUNA HILLS, Calif. , Oct. 11, 2017 ... London (ICR) and University of ... prognostic tool to risk-stratify patients with multiple myeloma (MM), in ... nine . The University of Leeds ... by Myeloma UK, and ICR will perform the testing services ...
(Date:10/10/2017)... ... October 10, 2017 , ... San Diego-based team building ... corporate rebranding initiative announced today. The bold new look is part of a ... company moves into a significant growth period. , It will also expand its service ...
(Date:10/10/2017)... firm Parks Associates announced today that Tom Kerber , ... Meeting , October 11 in Scottsdale, Arizona . Kerber ... smart safety and security products impact the competitive landscape. ... Parks Associates: Smart Home Devices: Main Purchase Driver ... "The residential security market has experienced continued growth, and the introduction ...
(Date:10/9/2017)... Oct. 9, 2017  BioTech Holdings announced today ... which its ProCell stem cell therapy prevents limb ... The Company, demonstrated that treatment with ProCell resulted ... saved as compared to standard bone marrow stem ... resulted in reduction of therapeutic effect.  ...
Breaking Biology Technology:
Cached News: